Dual antiplatelet Use for extended period taRgeted to AcuTe ischemic stroke with presumed atherosclerotic OrigiN (DURATION) trial: Rationale and design.
Kim JT, Kang J, Kim BJ, Kim JY, Han MK, Cho KH, Park MS, Choi KH, Park JM, Kang K, Kim YS, Lee SJ, Kim JG, Cha JK, Kim DH, Park TH, Park SS, Choi JK, Lee K, Park KY, Jeong HB, Lee J, Kwon DH, Cho YJ, Hong KS, Park HK, Lee BC, Yu KH, Oh MS, Lee M, Kim DE, Gwak DS, Choi JC, Kim JG, Kang CH, Kwon JH, Kim WJ, Shin DI, Yum KS, Sohn SI, Hong JH, Park H, Kim C, Lee SH, Lee J, Gorelick PB, Norrving B, Bae HJ.
Kim JT, et al. Among authors: park ss, park ky, park h, park ms, park th, park jm, park hk.
Int J Stroke. 2023 Oct;18(8):1015-1020. doi: 10.1177/17474930231168742. Epub 2023 Apr 25.
Int J Stroke. 2023.
PMID: 36974902
Clinical Trial.